Pharmaceutical Industry Blog

Telitacicept is a novel fusion protein designed to treat autoimmune diseases by targeting the B-cell maturation antigen (BCMA) and a...

Belimumab is a human monoclonal antibody designed to inhibit the B-cell activating factor (BAFF), also known as B-lymphocyte stimulator...

Linvoseltamab is an investigational bispecific antibody designed to target the B-cell maturation antigen (BCMA) on multiple myeloma cells...

Glofitamab is a bispecific monoclonal antibody designed to target CD20 and CD3, making it a promising treatment for large B-cell...

Belantamab is a monoclonal antibody designed to target the B-cell maturation antigen (BCMA), which is overexpressed in multiple myeloma...

Raxibacumab is a monoclonal antibody designed to treat and prevent inhalational anthrax, a severe infection caused by Bacillus anthracis...